MTRY Stock Overview
Monterey Innovation Acquisition Corp. does not have significant operations. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Monterey Innovation Acquisition Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$11.14 |
52 Week High | US$12.00 |
52 Week Low | US$10.18 |
Beta | 0 |
11 Month Change | -1.07% |
3 Month Change | n/a |
1 Year Change | 9.16% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 12.53% |
Recent News & Updates
Recent updates
Shareholder Returns
MTRY | US Capital Markets | US Market | |
---|---|---|---|
7D | 0% | 2.9% | 2.2% |
1Y | 9.2% | 57.5% | 31.7% |
Return vs Industry: MTRY exceeded the US Capital Markets industry which returned 8% over the past year.
Return vs Market: MTRY underperformed the US Market which returned 14.1% over the past year.
Price Volatility
MTRY volatility | |
---|---|
MTRY Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 3.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MTRY has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MTRY's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | n/a | Murat Omur | www.montereybio.com |
Monterey Innovation Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Monterey Bio Acquisition Corporation and changed its name to Monterey Innovation Acquisition Corp. in March 2023.
Monterey Innovation Acquisition Corp. Fundamentals Summary
MTRY fundamental statistics | |
---|---|
Market cap | US$48.30m |
Earnings (TTM) | -US$1.03m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-46.8x
P/E RatioIs MTRY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MTRY income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$1.03m |
Earnings | -US$1.03m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.24 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -77.6% |
How did MTRY perform over the long term?
See historical performance and comparison